CombiGene AB (publ) (COMBI.ST)

SEK 2.7

(-0.74%)

Eps Summary of CombiGene AB (publ)

  • CombiGene AB (publ)'s latest annual eps in 2023 was -1.80 SEK , down -566.67% from previous year.
  • CombiGene AB (publ)'s latest quarterly eps in 2024 Q2 was -0.38 SEK , up 47.22% from previous quarter.
  • CombiGene AB (publ) reported an annual eps of -0.27 SEK in 2022, down -122.31% from previous year.
  • CombiGene AB (publ) reported an annual eps of 1.21 SEK in 2021, up 136.23% from previous year.
  • CombiGene AB (publ) reported a quarterly eps of -0.72 SEK for 2024 Q1, down -125.0% from previous quarter.
  • CombiGene AB (publ) reported a quarterly eps of -0.74 SEK for 2023 Q1, down -23.33% from previous quarter.

Annual Eps Chart of CombiGene AB (publ) (2023 - 2012)

Historical Annual Eps of CombiGene AB (publ) (2023 - 2012)

Year Eps Eps Growth
2023 -1.80 SEK -566.67%
2022 -0.27 SEK -122.31%
2021 1.21 SEK 136.23%
2020 -3.34 SEK 44.43%
2019 -6.01 SEK 38.55%
2018 -9.78 SEK 13.45%
2017 -11.30 SEK -39.85%
2016 -8.08 SEK -32.68%
2015 -6.09 SEK -180.65%
2014 -2.17 SEK -2167.5%
2013 -0.10 SEK -66.43%
2012 -0.06 SEK 0.0%

Peer Eps Comparison of CombiGene AB (publ)

Name Eps Eps Difference
Alligator Bioscience AB (publ) -0.55 SEK -227.273%
Ziccum AB (publ) -1.54 SEK -16.883%
Modus Therapeutics Holding AB (publ) -1.01 SEK -78.218%
BioArctic AB (publ) 2.60 SEK 169.231%
Sprint Bioscience AB (publ) -0.01 SEK -28471.429%
Mendus AB (publ) -4.40 SEK 59.091%
Genovis AB (publ.) 0.94 SEK 291.489%
Intervacc AB (publ) -1.69 SEK -6.509%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK -718.182%
Active Biotech AB (publ) -0.17 SEK -958.824%
Magle Chemoswed Holding AB (publ) 1.13 SEK 259.292%
Bio-Works Technologies AB (publ) -1.57 SEK -14.65%
Aptahem AB (publ) -0.05 SEK -3626.708%
Vicore Pharma Holding AB (publ) -3.22 SEK 44.099%
Kancera AB (publ) -0.80 SEK -125.0%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 81.91%
Fluicell AB (publ) -0.24 SEK -650.0%
Saniona AB (publ) -1.29 SEK -39.535%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK -847.368%
Biovica International AB (publ) -2.14 SEK 15.888%
Spago Nanomedical AB (publ) -0.43 SEK -318.605%
AcouSort AB (publ) -1.29 SEK -39.535%
Xintela AB (publ) -0.13 SEK -1284.615%
Abliva AB (publ) -0.09 SEK -1891.15%
Egetis Therapeutics AB (publ) -1.27 SEK -41.732%
Karolinska Development AB (publ) 0.02 SEK 9100.0%
OncoZenge AB (publ) -1.36 SEK -32.353%
Amniotics AB (publ) -0.01 SEK -16263.636%
2cureX AB (publ) -1.85 SEK 2.703%
Asarina Pharma AB (publ) -0.57 SEK -215.789%
Calliditas Therapeutics AB (publ) -8.69 SEK 79.287%
Camurus AB (publ) 7.78 SEK 123.136%
Corline Biomedical AB -0.08 SEK -2037.767%
IRLAB Therapeutics AB (publ) -3.43 SEK 47.522%
Isofol Medical AB (publ) -0.23 SEK -682.609%
I-Tech AB 1.70 SEK 205.882%
Hansa Biopharma AB (publ) -15.83 SEK 88.629%
Cyxone AB (publ) -0.22 SEK -718.182%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 9.091%
Biosergen AB -0.60 SEK -200.0%
Cantargia AB (publ) -1.65 SEK -9.091%
NextCell Pharma AB -1.03 SEK -74.757%
Xspray Pharma AB (publ) -6.76 SEK 73.373%
Elicera Therapeutics AB (publ) -0.83 SEK -116.867%
Nanologica AB (publ) -2.05 SEK 12.195%
SynAct Pharma AB -6.64 SEK 72.892%
Annexin Pharmaceuticals AB (publ) -0.26 SEK -592.308%
Stayble Therapeutics AB (publ) -0.92 SEK -95.652%
LIDDS AB (publ) -0.63 SEK -185.714%
Lipum AB (publ) -4.45 SEK 59.551%
BioInvent International AB (publ) -5.02 SEK 64.143%
Alzinova AB (publ) -0.41 SEK -339.024%
Oncopeptides AB (publ) -1.96 SEK 8.163%
Pila Pharma AB (publ) -0.47 SEK -282.979%
Guard Therapeutics International AB (publ) -11.26 SEK 84.014%
Scandinavian ChemoTech AB (publ) -1.13 SEK -59.292%
Simris Alg AB (publ) -0.16 SEK -1025.0%
Diamyd Medical AB (publ) -1.60 SEK -12.5%
Xbrane Biopharma AB (publ) -1.27 SEK -41.732%
Ascelia Pharma AB (publ) -3.24 SEK 44.444%
Diagonal Bio AB (publ) -0.32 SEK -462.5%